Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients

Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients Publisher Pubmed

Sharifynia S^{1, 2} ; Rezaie S² ; Mohamadnia A³ ; Mortezaee V⁴ ; Hadian A² ; Seyedmousavi S^{4, 5, 6, 7}

Source: Medical Mycology Published:2019

Abstract

A total of 105 independent Candida albicans strains isolated from patients in Iran were investigated. According to CLSI documents M27-A3 and M27-S4, the 24 h geometric mean MICs of caspofungin, itraconazole, and fluconazole were 0.27, 3.19, and 11.91 μg/ml, respectively. Microsatellites analysis of CEF3, CAIII, LOC4 Loci identified 93 different allelic genotypes clustered apart into six different clades. Antifungal susceptibility was not linked with the source of isolation and the corresponding genotype of C. albicans strains. © The Author(s) 2018. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved.

Related Docs

View other Related Docs

1. Caspofungin-Non-Susceptible Candida Orthopsilosis Isolated From Onychomycosis in Iran, Iranian Journal of Public Health (2017)

2. Low Level of Antifungal Resistance in Iranian Isolates of Candida Glabrata Recovered From Blood Samples in a Multicenter Study From 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of Pdr1, Antimicrobial Agents and Chemotherapy (2019)

3. In Vitro Antifungal Susceptibility Profiles of Candida Albicans Complex Isolated From Patients With Respiratory Infections, Acta Medica Iranica (2016)

Experts (# of related papers)

View all Related Experts

Mohammadreza Salehi (5)

Sassan Rezaie (4)

Style	Citing Format
MLA	Sharifynia S, et al.. "Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients." Medical Mycology, vol. 57, no. 1, 2019, pp. 127-131.
APA	Sharifynia S, Rezaie S, Mohamadnia A, Mortezaee V, Hadian A, Seyedmousavi S (2019). Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients. Medical Mycology, 57(1), 127-131.
Chicago	Sharifynia S, Rezaie S, Mohamadnia A, Mortezaee V, Hadian A, Seyedmousavi S. "Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients." Medical Mycology 57, no. 1 (2019): 127-131.
Harvard	Sharifynia S et al. (2019) 'Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients', Medical Mycology, 57(1), pp. 127-131.
Vancouver	Sharifynia S, Rezaie S, Mohamadnia A, Mortezaee V, Hadian A, Seyedmousavi S. Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients. Medical Mycology. 2019;57(1):127-131.
BibTex	@article{ author = {Sharifynia S and Rezaie S and Mohamadnia A and Mortezaee V and Hadian A and Seyedmousavi S}, title = {Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients}, journal = {Medical Mycology}, volume = {57}, number = {1}, pages = {127-131}, year = {2019} }
RIS	TY - JOUR AU - Sharifynia S AU - Rezaie S AU - Mohamadnia A AU - Mortezaee V AU - Hadian A AU - Seyedmousavi S TI - Genetic Diversity and Antifungal Susceptibility of Candida Albicans Isolated From Iranian Patients JO - Medical Mycology VL - 57 IS - 1 SP - 127 EP - 131 PY - 2019 ER -

Science Communicator Platform

Authors

Abstract